Brenda Shanahan

Brenda Shanahan served in senior executive and board roles in Australia and overseas primarily in stockbroking, funds management and investment consulting. She is a director of Clinuvel Pharmaceuticals, Bell Financial Group, Phoslock Environment Technologies, and DMP Asset Management. She is also a member of Swinburne University Industry Advisory Board, and the Australian Advisory Board on Technology and Healthcare Competitiveness. Ms Shanahan was chair of St Vincent’s Institute of Medical Research and is a member of the SVI Foundation. She was a director of Challenger Limited, member of the Australian Stock Exchange, partner of May Mellor Laing & Cruikshank, principal of Investment Consulting, and worldwide partner at WM Mercer.
Bio last updated 27 Nov 2018

Access to our data for Brenda Shanahan is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

Brenda Shanahan is linked to 1 organisation which is included in 1 list - Philanthropic Foundations.

To see the data you will need to .


Non-Executive Director, Treasurer (since 2011)
Year started and most recent title

BNiQ Disclaimer